SXTP (60degreespharma.com) רווח נקי למניה (EPS TTM)

60 Degrees Pharmaceuticals (SXTP) is valued by humanitarian organizations for its fight against malaria. Earnings per share for the last four quarters in the GURU.Markets system contains current dynamics, where the latest value is recorded as -6.16. The company is developing small molecule bioengineering for the drug Arakoda, and its success relies on US government defense contracts and scientific grants.

This metric is calculated as the ratio of total annual net income to the total number of shares outstanding. This metric determines the actual efficiency of capital management and the investor's equity return. The stability of 60 Degrees Pharmaceuticals (SXTP) supply chains converts directly into the operational resilience of this profit. An analysis of earnings per share over the last four quarters reveals hidden profitability trends. This chart's price action serves as a leading indicator of changes in the fundamental quality of the business.